Latest Astellas Pharma Inc. Stories
NORTHBROOK, Ill., Feb. 13, 2015 /PRNewswire/ -- Astellas Pharma Inc.
TOKYO, Feb. 2, 2015 /PRNewswire/ -- Astellas Pharma Inc.
HERSHEY, Pa., Rockville, Md. and TOKYO, Jan. 29, 2015 /PRNewswire/ -- Immunomic Therapeutics, Inc.
TOKYO, Jan. 15, 2015 /PRNewswire/ -- Astellas Pharma Inc. ("Astellas," Tokyo: 4503) today announced that Eric Terhaerdt has been named senior vice president of Global Development Operations.
DUBLIN, Ohio, Jan. 7, 2015 /PRNewswire-USNewswire/ -- Astellas Pharma US, Inc.
ReportsnReports.com adds “Heart Transplantation - Pipeline Review, H2 2014” to its store.
Focus on research and development for small molecule inhibitors of oncogenic K-Ras - the most commonly mutated oncogene in human cancers BOSTON and TOKYO, Nov.
More than 6,000 employees worldwide have already completed over 13,000 hours of volunteer service in their communities TOKYO, Nov. 4, 2014 /PRNewswire/ -- Astellas Pharma Inc.
HILDEN, Germany and TOKYO, October 28, 2014 /PRNewswire/ -- - First two programs aim to create tests to aid in cancer treatment with Astellas compounds
- AIMing to establish a new treatment for ophthalmologic diseases - TOKYO, Oct. 14, 2014 /PRNewswire/ -- Astellas Pharma Inc.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.